Cano Health (CANO) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Atmosphere Clean Climate Climate Change Ecosystem Environment Environmental Extreme Weather Intensity Materials Natural Resources Nature Offset Package Packaging Pandemic Scarcity Waste Access Affordability African American Attrition Benefits Black Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographic Demographics Disability Diversity Diversity and Inclusion Employee Engagement Ethnic Ethnicity Gender Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Latinx Minority Opioid Overtime Pay for Performance Perquisites Privacy Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Societal Stakeholder Supplier Supply Chain Talent Training Union Workers Workforce Working Condition Activist Assessment Assurance Attorneys General Audit Bonus Bribe Chronic Class Action Lawsuit Classified Classified Board Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Enterprise Risk Management Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Key Performance Indicator Lawsuit Lead Independent Director Leadership Litigant Litigation Long-term Majority Materiality Mission Oversee Oversight Perquisite Plaintiff Pledging Proxy Contest Purpose Reputation Reputational Responsibility Responsible Special Meeting Strategy Supermajority Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 16, 2022, Cano Health, Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “Annual Meeting”). There were 481,749,071 shares of the Company’s Class A common stock and Class B common stock outstanding and entitled to vote at the Annual Meeting. 433,064,494 shares of the Company’s Class A common stock and Class B common stock were represented in person or by proxy at the Annual Meeting, which constituted a quorum for the purpose of transacting business.

At the Annual Meeting, the Company’s stockholders voted upon the following four matters:

1. The election of Dr. Lewis Gold, Barry S. Sternlicht and Solomon D. Trujillo as Class I directors, each to serve on the Company’s Board of Directors for a three-year term and until their respective successors are duly elected and qualified.

2. The approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers.

3. The approval of a non-binding advisory resolution on whether an advisory vote on executive compensation should be held every one, two or three years.

4. The ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

The final voting results for each proposal are set forth below:

Proposal 1 - Election of Class I Directors

Director Nominee	Votes For	Withheld	Broker Non-Vote

Dr. Lewis Gold	389,739,710	24,442,791	18,881,993
Barry S. Sternlicht	366,809,590	47,372,911	18,881,993
Solomon D. Trujillo	392,105,689	22,076,812	18,881,993

Each of the three director nominees listed above received the number of votes set forth opposite his name, constituting in each case a plurality of the votes cast at the Annual Meeting for the election of such director to serve on the Board of Directors for a term of three years and until his successor is duly elected and qualified.

Proposal 2 - Advisory Vote on Compensation of Named Executive Officers


			Number
Votes For			400,342,807
Votes Against			13,314,689
Abstentions			525,005
Broker Non-Votes			18,881,993

The non-binding advisory resolution regarding the compensation of the Company’s named executive officers was approved by the affirmative vote of a majority of the shares of common stock present or represented by proxy at the Annual Meeting.

Proposal 3 - Advisory Vote on Frequency of an Advisory Vote on Compensation of Named Executive Officers


1 Year	2 Years	3 Years	Abstentions	Broker Non-Vote
410,348,928	1,448,818	133,435	2,251,320	18,881,993

An advisory vote on executive compensation to be held annually received the highest number of votes of the shares of common stock present or represented by proxy at the Annual Meeting.

Proposal 4 - Ratification of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the Year Ending December 31, 2022


			Number
Votes For			414,996,206
Votes Against			17,977,823
Abstentions			90,465

The ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was approved by the affirmative vote of a majority of the shares of common stock present or represented by proxy at the Annual Meeting.